Evidence map›Paper›PMID 31833833›Full record

ArticleeLife2019

Axon-like protrusions promote small cell lung cancer migration and metastasis.

Dian Yang, Fangfei Qu, Hongchen Cai, Chen-Hua Chuang, Jing Shan Lim, Nadine Jahchan, Barbara M Grüner, Christin S Kuo, Christina Kong, Madeleine J Oudin and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Molecular mechanisms and therapeutic targets in lung cancer-nerve crosstalk.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Current and future therapies for small cell lung carcinoma.Journal of hematology & oncology · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Dian YangCancer Biology Program, Stanford University School of Medicine, Stanford, United States.
Fangfei QuDepartment of Pediatrics, Stanford University School of Medicine, Stanford, United States.
Hongchen CaiDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.
Chen-Hua ChuangDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.
Jing Shan LimCancer Biology Program, Stanford University School of Medicine, Stanford, United States.
Nadine JahchanDepartment of Pediatrics, Stanford University School of Medicine, Stanford, United States.
Barbara M GrünerDepartment of Genetics, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0003-0974-4826
Christin S KuoDepartment of Pediatrics, Stanford University School of Medicine, Stanford, United States.
Christina KongDepartment of Pathology, Stanford University School of Medicine, Stanford, United States.
Madeleine J OudinDepartment of Biomedical Engineering, Tufts University, Medford, United States.
Monte M WinslowCancer Biology Program, Stanford University School of Medicine, Stanford, United States.
Julien SageCancer Biology Program, Stanford University School of Medicine, Stanford, United States.ORCID 0000-0002-8928-9968
Stanford University · USEssen University Hospital · DETufts University · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Single-Cell Biology and Data Analysis Shared Resource (SCB-DA SR)U54CA217450 · NCI · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2018 to 2022
$8.5M
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategiesR35CA231997 · NCI · STANFORD UNIVERSITY · PI SAGE, JULIEN · 2019 to 2025
$6.2M
Molecular mechanisms of SCLC initiation and detection in mice and humansU01CA231851 · NCI · STANFORD UNIVERSITY · PI KRASNOW, MARK A · 2018 to 2022
$2.9M
Molecular and cellular mechanisms of SCLC metastasisR01CA206540 · NCI · STANFORD UNIVERSITY · PI SAGE, JULIEN · 2016 to 2019
$1.7M
Investigating the role of the extracellular matrix in metastasis and chemo-resistanceR00CA207866 · NCI · TUFTS UNIVERSITY MEDFORD · PI OUDIN, MADELEINE JULIE · 2018 to 2020
$696k
NCI NIH HHS NIH R01 CA206540NCI NIH HHS P30 CA124435NCI NIH HHS R00 CA207866NCI NIH HHS R01 CA206540NCI NIH HHS R35 CA231997NCI NIH HHS U01 CA231851NCI NIH HHS U54 CA217450Tobacco-Related Disease Research Program 24DT-0001
6 · The paper itself

Abstract

Metastasis is the main cause of death in cancer patients but remains a poorly understood process. Small cell lung cancer (SCLC) is one of the most lethal and most metastatic cancer types. SCLC cells normally express neuroendocrine and neuronal gene programs but accumulating evidence indicates that these cancer cells become relatively more neuronal and less neuroendocrine as they gain the ability to metastasize. Here we show that mouse and human SCLC cells in culture and in vivo can grow cellular protrusions that resemble axons. The formation of these protrusions is controlled by multiple neuronal factors implicated in axonogenesis, axon guidance, and neuroblast migration. Disruption of these axon-like protrusions impairs cell migration in culture and inhibits metastatic ability in vivo. The co-option of developmental neuronal programs is a novel molecular and cellular mechanism that contributes to the high metastatic ability of SCLC.

Indexed as

Cell MovementAnimalsCell Surface ExtensionsHumansLung NeoplasmsMiceNeoplasm MetastasisSmall Cell Lung CarcinomaTumor Cells, Culturedcancer biologycell biologyhumanmetastasismigrationmouseneuroendocrineneuronalprotrusionsSCLC

Identifiers

PMID31833833
PMCPMC6940020
OpenAlexW2995604441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.